Overview

Reducing Blood Loss During Cesarean Myomectomy With Tranexamic Acid

Status:
Completed
Trial end date:
2020-03-01
Target enrollment:
Participant gender:
Summary
This study was a double-blinded randomized controlled study conducted at Aswan University, Egypt from January 2018 to January 2020. Study inclusion criteria were women who attended the outpatient obstetric clinic, seeking antenatal care diagnosed with leiomyomas with pregnancy and with myoma staging from (3 to 6) according to FIGO staging. scheduled to undergo cesarean myomectomy (11) Exclusion criteria were: 1-Patients undergone vaginal delivery.2-Patients with a history of thromboembolic disease. 3-Cervical and broad ligament myoma. 4-Myoma FIGO staging
Phase:
N/A
Details
Lead Sponsor:
Aswan University Hospital
Treatments:
Tranexamic Acid